person

Pilar G.

Country
Spain
Department
Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
6
Sites with multiple studies

Has run more than one trial at 6 of 36 partner sites.

Specializations

Pediatric Hematologic Malignancies

Focus on childhood blood cancers, including Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia, with emphasis on high‑risk and relapsed disease.

  • Risk‑adapted chemotherapy protocols
  • Minimal residual disease monitoring
  • Targeted agents for FLT3‑mutated AML

Research integrates molecular profiling to refine therapeutic stratification.

Pediatric Solid Tumors and Sarcomas

Investigation of solid malignancies such as osteosarcoma, Ewing sarcoma, and high‑grade glioma, addressing both localized and metastatic disease.

  • Neoadjuvant and adjuvant multimodal regimens
  • Biomarker‑driven targeted therapies
  • Precision surgery combined with systemic treatment

Efforts aim to improve survival while reducing treatment‑related toxicity.

Bone Marrow Transplant and Graft‑Versus‑Host Disease

Clinical work on pediatric hematopoietic stem cell transplantation, focusing on prevention and management of acute graft‑versus‑host disease and related complications.

  • Optimized conditioning regimens
  • Prophylactic immunosuppression strategies
  • Biomarker‑guided early intervention

Studies seek to enhance engraftment success and long‑term graft tolerance.

Immunotherapy and Cellular Therapies

Application of novel immune‑based approaches, including CAR T‑cell therapy and bispecific antibodies, for refractory pediatric malignancies.

  • Safety and efficacy assessment in acute lymphoblastic leukemia
  • Combination with checkpoint inhibition
  • Manufacturing and delivery optimization for children

Goal is to expand curative options beyond conventional chemotherapy.

Pediatric Infectious and Metabolic Complications

Study of opportunistic infections such as nontuberculous mycobacterial lung disease and metabolic liver disorders including non‑alcoholic steatohepatitis in immunocompromised children.

  • Diagnostic biomarker development
  • Therapeutic regimens tailored to pediatric pharmacokinetics
  • Integration with oncology supportive care

Research supports comprehensive management of comorbid conditions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.